Trademarkia Logo

Canada

C$
RejuvenRx
ADVERTISED

on 10 Jan 2025

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

RejuvenRx Inc.

2950 chemin PolytechniqueMontréal

QUEBEC

CA

H3T1J4

Serial Number

2073225 filed on 23rd Dec 2020

Registration Number

TMA1282249 registered on 10th Jan 2025

Registration expiry Date

10th Jan 2035

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

RejuvenRx

Trademark usage description

pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system d Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system diseases and disorders, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease.


Classification kind code

11

Class [042]
Development of pharmaceutical preparations and medicines.


Classification kind code

11

Mark Details


Serial Number

2073225

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 10th Jan 2025
Registration Pending
Submitted for opposition 42
on 23rd Oct 2024
Advertised
Submitted for opposition 26
on 26th Sept 2024
Approved
Submitted for opposition 27
on 26th Sept 2024
Approval Notice Sent
Submitted for opposition 22
on 18th Sept 2024
Search Recorded
Submitted for opposition 67
on 15th Dec 2023
Agent Name Changed
Submitted for opposition 287
on 27th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 23rd Dec 2020
Filed
Submitted for opposition 1
on 23rd Dec 2020
Created
Submitted for opposition 31
on 23rd Dec 2020
Formalized